Medicare Enrolled
Dr. Edmund Bermudez, M.D.
Cardiovascular Disease · North Venice, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Bermudez from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bermudez? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Bermudez
Dr. Edmund Bermudez is a cardiovascular disease in North Venice, FL, with 19 years in practice. Based on federal Medicare data, Dr. Bermudez performed 9,824 Medicare services across 6,476 unique beneficiaries.
Between the years covered by Open Payments, Dr. Bermudez received a total of $8,128 from 31 pharmaceutical and/or device companies across 205 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Bermudez is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 8% volume in FL$ $8,128 industry payments
Medicare Practice Summary
Medicare Utilization ↗9,824
Medicare services
Top 8% in FL for cardiovascular disease
6,476
Unique beneficiaries
$44
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~517 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| EKG interpretation and report | 2,776 | $6 | $17 |
| Office visit, established patient (30-39 min) | 1,192 | $90 | $219 |
| Electrocardiogram (EKG), 12-lead | 889 | $10 | $42 |
| Prothrombin time test (blood clotting) | 617 | $4 | $28 |
| Anticoagulant management of patient taking warfarin | 578 | $8 | $23 |
| Regadenoson injection (Lexiscan) for heart stress test | 380 | $44 | $78 |
| Echocardiogram, transthoracic | 326 | $138 | $429 |
| Hospital follow-up visit, moderate complexity | 274 | $61 | $148 |
| Remote pacemaker/defibrillator monitoring, 90 days | 250 | $15 | $66 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 240 | $88 | $236 |
| Remote pacemaker monitoring, 90 days | 187 | $21 | $68 |
| Initial hospital admission, moderate complexity | 184 | $101 | $283 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 178 | $18 | $55 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 178 | $25 | $72 |
| Programming of dual lead pacemaker system | 139 | $55 | $156 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 137 | $48 | $168 |
| New patient office visit (45-59 min) | 123 | $114 | $333 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 118 | $332 | $793 |
| Hospital follow-up visit, high complexity | 93 | $93 | $213 |
| Physician review, interpretation, and patient management of home inr testing for patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; testing not occurring more frequent | 77 | $6 | $19 |
| Initial hospital admission, high complexity | 65 | $132 | $415 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 63 | $27 | $129 |
| Ultrasound of both sides of head and neck blood flow | 56 | $133 | $427 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 52 | $8 | $30 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 52 | $17 | $50 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 52 | $10 | $26 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 50 | $16 | $44 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 50 | $11 | $30 |
| Heart rhythm recording of continous external ekg over 8-15 days | 44 | $9 | $30 |
| Office visit, established patient, complex (40-54 min) | 43 | $140 | $294 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 40 | $20 | $55 |
| Ultrasound of heart with probe in esophagus, with report | 34 | $81 | $219 |
| Programming of multiple lead implantable defibrillator system | 33 | $69 | $209 |
| Replacement of aortic valve through the skin and femoral artery | 32 | $617 | $3,058 |
| Cardiac catheterization | 30 | $200 | $737 |
| Office visit, established patient (20-29 min) | 28 | $70 | $151 |
| Injection, aminophyllin, up to 250 mg | 24 | $7 | $35 |
| Blood draw (venipuncture) | 23 | $8 | $17 |
| Ultrasonic guidance for blood vessel access | 23 | $12 | $31 |
| Ultrasound of heart, follow-up | 23 | $75 | $194 |
| Hospital follow-up visit, low complexity | 18 | $40 | $86 |
| Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | 15 | $241 | $826 |
| Coronary stent placement | 14 | $444 | $1,360 |
| 3d ultrasound imaging of heart for evaluation of heart structure performed during ultrasound imaging of congenital heart defects | 13 | $19 | $52 |
| Repair of left upper heart chamber with implant with review by radiologist | 11 | $616 | $2,021 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
11.9% high complexity
9.0% medium
79.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$8,128
Total received (2018-2024)
Avg $1,161/year across 7 years
Top 29% in FL for cardiovascular disease
31
Companies
205
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,128 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$774
2023$854
2022$2,240
2021$571
2020$338
2019$852
2018$2,498
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Edwards Lifesciences Corporation
$1,650
Boston Scientific Corporation
$1,217
Abbott Laboratories
$1,173
Medtronic Vascular, Inc.
$1,121
BIOTRONIK INC.
$792
Janssen Pharmaceuticals, Inc
$368
ABIOMED
$322
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$215
Medtronic, Inc.
$164
Penumbra, Inc.
$149
BOSTON SCIENTIFIC CORPORATION
$140
Cleerly, Inc.
$133
Amgen Inc.
$124
Novartis Pharmaceuticals Corporation
$73
CVRx, Inc.
$50
Bard Peripheral Vascular, Inc.
$48
AstraZeneca Pharmaceuticals LP
$46
E.R. Squibb & Sons, L.L.C.
$44
Terumo Medical Corporation
$39
Novo Nordisk Inc
$38
Astellas Pharma US Inc
$34
SANOFI-AVENTIS U.S. LLC
$30
Kestra Medical Technology Services, Inc.
$28
Amarin Pharma Inc.
$23
Merck Sharp & Dohme LLC
$19
Impulse Dynamics (USA) Inc.
$19
Braemar Manufacturing, LLC
$18
Cardiovascular Systems Inc.
$15
PFIZER INC.
$13
GE HEALTHCARE
$12
Allergan Inc.
$11
Top 3 companies account for 49.7% of total payments
Associated products mentioned in payments ›
AMPLATZER AMULET · AMPLATZER Occluders · AMVIA EDGE · AVEIR · AZURE XT DR MRI SURESCAN · Acticor · Acticor 7 VR-T DX · Assure WCD · BIOMONITOR · BRILINTA · BYSTOLIC · Barostim Neo System · COMET · CONFIRM RX · COROFLOW · Cardiac Monitoring Suite · CardioMEMS HF System · Cleerly Ischemia · Confirm Rx · CoreValve Evolut · EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) · ELIQUIS · ENTRESTO · Edwards SAPIEN 3 Transcatheter Heart Valve · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · GENERAL STRUCTURAL HEART · GENERAL STENTS · GENERAL - STRUCTURAL HEART · GLIDESHEATH SLENDER · GUIDEZILLA · HI-TORQUE COMMAND · Impella · Indigo · Indigo System · LEQVIO · LEXISCAN · LUX-Dx Insertable Cardiac Monitor · Legacy · LifeVest · MICRA · MITRACLIP · MULTAQ · Micra · Mitra Clip system · MitraClip System · OptiCross · Optimizer · Orsiro Mission · PERCLOSE PROGLIDE · PRALUENT · PROMUS · Penumbra System · Perclose ProGlide suture mediated closure system · Peripheral Orbital Atherectomy System · PressureWire FFR · RESONATE · ROTABLATOR · ROTAPRO · Repatha · Rivacor · Rotablator Rotational Atherectomy System Console Kit · Rybelsus · SAMURAI · SAPIEN 3 Ultra RESILIA · Solia · TRUE · VERQUVO · Vascepa · WATCHMAN · WATCHMAN Access System · WOLVERINE · Wegovy · XARELTO · Xience Sierra Coronary Stent
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $83 per 100 Medicare services performed
Geographic Context
Cardiovascular Diseases within 10 mi
84
Per 100K population
18.7
County median income
$80,633
Nearest hospital
SARASOTA MEMORIAL HOSPITAL - VENICE
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Bermudez is a clinical cardiology specialist, with above-average Medicare volume (top 8% in FL), and low-engagement industry engagement, with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Bermudez experienced with ekg interpretation and report?
Based on Medicare claims data, Dr. Bermudez performed 2,776 ekg interpretation and report services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Bermudez receive payments from pharmaceutical companies?
Yes. Dr. Bermudez received a total of $8,128 from 31 companies across 205 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bermudez's costs compare to other cardiovascular diseases in North Venice?
Dr. Bermudez's average Medicare payment per service is $44. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bermudez) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiovascular Diseases in North Venice
Browse cardiovascular diseases in North Venice ranked by procedure volume and transparency data.
Highest volume
Top Cardiovascular Diseases in FL
Cardiovascular Diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiovascular Diseases in FL
Which FL cardiovascular diseases receive the most from drug and device companies.
By company
Edwards Lifesciences Corporation Payments to Doctors
See all physicians who received payments from Edwards Lifesciences Corporation.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology